HER-2/neu amplification or overexpression can make cancer cells resistant t
o apoptosis and promotes their growth. p53 is crucial in regulating cell gr
owth and apoptosis, and is often mutated or deleted in many types of tumour
. Moreover, many turnours with a wild-type gene for p53 do not have normal
p53 function, suggesting that some oncogenic signals suppress the function
of p53. In this study, we show that HER-2/neu-mediated resistance to DNA-da
maging agents requires the activation of Akt, which enhances MDM2-mediated
ubiquitination and degradation of p53. Akt physically associates with MDM2
and phosphorylates it at Ser166 and Ser186. Phosphorylation of MDM2 enhance
s its nuclear localization and its interaction with p300, and inhibits its
interaction with P19(ARF), thus increasing p53 degradation. Our study indic
ates that blocking the Akt pathway mediated by HER-2/neu would increase the
cytotoxic effect of DNA-damaging drugs in tumour cells with wild-type p53.